{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:25:35Z","timestamp":1740108335607,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T00:00:00Z","timestamp":1551744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00228-019-02651-y","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T04:03:01Z","timestamp":1551758581000},"page":"985-994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of medication and off-label medication use in acquired brain injury at a neurorehabilitation hospital"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6645-9098","authenticated-orcid":false,"given":"Raquel","family":"Merino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josana","family":"Fierro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Terr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,5]]},"reference":[{"key":"2651_CR1","first-page":"114","volume":"35","author":"A Villafaina","year":"2011","unstructured":"Villafaina A, Gavil\u00e1n E (2011) Pacientes polimedicados fr\u00e1giles, un reto para el sistema sanitario. Inf Ter Sist Nac Salud 35:114\u2013123","journal-title":"Inf Ter Sist Nac Salud"},{"key":"2651_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12603-013-0337-8","volume":"18","author":"N Husson","year":"2014","unstructured":"Husson N, Watfa G, Laurain MC, Perret-Guillaume C, Niemier JY, Benetos A (2014) Characteristics of polymedicated (\u2265 4) elderly: a survey in a community-dwelling population aged 60 years and over. J Nutr Health Aging 18:87\u201391. \n                    https:\/\/doi.org\/10.1007\/s12603-013-0337-8","journal-title":"J Nutr Health Aging"},{"key":"2651_CR3","doi-asserted-by":"publisher","first-page":"193168","DOI":"10.1155\/2012\/193168","volume":"2012","author":"A Vyas","year":"2012","unstructured":"Vyas A, Pan X, Sambamoorthi U (2012) Chronic condition clusters and polypharmacy among adults. Int J Family Med 2012:193168. \n                    https:\/\/doi.org\/10.1155\/2012\/193168","journal-title":"Int J Family Med"},{"key":"2651_CR4","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.2147\/CIA.S52698","volume":"8","author":"Y Beloosesky","year":"2013","unstructured":"Beloosesky Y, Nenaydenko O, Gross Nevo RF, Adunsky A, Weiss A (2013) Rates, variability and associated factors of polypharmacy in nursing home patients. Clin Interv Aging 8:1585\u20131590. \n                    https:\/\/doi.org\/10.2147\/CIA.S52698","journal-title":"Clin Interv Aging"},{"key":"2651_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3109\/02699052.2015.1118767","volume":"30","author":"G Cosano","year":"2017","unstructured":"Cosano G, Giangreco M, Ussai S, Giorgini T, Biasutti E, Barbone F, Pisa FE, Group for the Study of Medication Use in Centres for Post-acute Brain Injury Rehabilitation (2017) Polypharmacy and the use of medications in inpatients with acquired brain injury during post-acute rehabilitation: a cross-sectional study. Brain Inj 30:353\u2013362. \n                    https:\/\/doi.org\/10.3109\/02699052.2015.1118767","journal-title":"Brain Inj"},{"key":"2651_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ncl.2010.10.008","volume":"29","author":"S Riggio","year":"2011","unstructured":"Riggio S (2011) Traumatic brain injury and its neurobehavioral sequelae. Neurol Clin 29:35\u201347. \n                    https:\/\/doi.org\/10.1016\/j.ncl.2010.10.008","journal-title":"Neurol Clin"},{"key":"2651_CR7","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1080\/02699050701765700","volume":"21","author":"JM Rogers","year":"2007","unstructured":"Rogers JM, Read CA (2007) Psychiatric comorbidity following traumatic brain injury. Brain Inj 21:1321\u20131333. \n                    https:\/\/doi.org\/10.1080\/02699050701765700","journal-title":"Brain Inj"},{"key":"2651_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3109\/02699052.2014.989904","volume":"29","author":"TS Webb","year":"2015","unstructured":"Webb TS, Whitehead CR, Wells TS, Gore RK, Otte CN (2015) Neurologically-related sequelae associated with mild traumatic brain injury. Brain Inj 29:430\u2013437. \n                    https:\/\/doi.org\/10.3109\/02699052.2014.989904","journal-title":"Brain Inj"},{"key":"2651_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11940-000-0017-y","volume":"2","author":"DB Arciniegas","year":"2000","unstructured":"Arciniegas DB, Topkoff J, Silver JM (2000) Neuropsychiatric aspects of traumatic brain injury. Curr Treat Options Neurol 2:169\u2013186","journal-title":"Curr Treat Options Neurol"},{"key":"2651_CR10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/msj.20097","volume":"73","author":"TA Ashman","year":"2006","unstructured":"Ashman TA, Gordon WA, Cantor JB, Hibbard MR (2006) Neurobehavioral consequences of traumatic brain injury. Mt Sinai J Med 73:999\u20131005. \n                    https:\/\/doi.org\/10.1002\/msj.20097","journal-title":"Mt Sinai J Med"},{"key":"2651_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3109\/02699052.2014.992474","volume":"29","author":"FE Pisa","year":"2015","unstructured":"Pisa FE, Cosano G, Giangreco M, Giorgini T, Biasutti E, Barbone F, Group for the Study of Medication Use in Centers for Post-acute Brain Injury Rehabilitation (2015) Prescribing practice and off-label use of psychotropic medications in post-acute brain injury rehabilitation centres: a cross-sectional survey. Brain Inj 29:508\u2013516. \n                    https:\/\/doi.org\/10.3109\/02699052.2014.992474","journal-title":"Brain Inj"},{"key":"2651_CR12","doi-asserted-by":"publisher","first-page":"S256-e.e14","DOI":"10.1016\/j.apmr.2015.01.025","volume":"96","author":"F Hammond","year":"2015","unstructured":"Hammond F, Barret R, Shea T, Seel R, Mc Allister T, Kaelin D et al (2015) Psychotropic medication use during inpatient rehabilitation for traumatic brain injury. Arch Phys Med Rehabil 96:S256-e.e14. \n                    https:\/\/doi.org\/10.1016\/j.apmr.2015.01.025","journal-title":"Arch Phys Med Rehabil"},{"key":"2651_CR13","first-page":"118","volume":"63","author":"M Rappaport","year":"1982","unstructured":"Rappaport M, Hall KM, Hopkins K, Belleza T, Cope DN (1982) Disability rating scale for severe head trauma: coma to community. Arch Phys Med Rehabil 63:118\u2013123","journal-title":"Arch Phys Med Rehabil"},{"key":"2651_CR14","first-page":"87","volume-title":"Rehabilitation of the head injured adult","author":"C Hagen","year":"1979","unstructured":"Hagen C, Malkmus D, Durham P (1979) Levels of cognitive functioning. In: Professional Staff Association of Rancho Los Amigos National Rehabilitation Center (ed) Rehabilitation of the head injured adult. Comprehensive Physical Management, Downey, pp 87\u201388"},{"key":"2651_CR15","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel index. Md State Med J 14:61\u201365","journal-title":"Md State Med J"},{"key":"2651_CR16","volume-title":"Guide for the use of the uniform data set for medical rehabilitation","author":"CV Granger","year":"1986","unstructured":"Granger CV, Hamilton BB, Sherwin FS (1986) Guide for the use of the uniform data set for medical rehabilitation. Uniform Data System for Medical Rehabilitation Project Office, Buffalo General Hospital, New York"},{"key":"2651_CR17","unstructured":"National Institute of Health, National Institute of Neurological Disorders and Stroke (2018) Stroke Scale \n                    https:\/\/www.ninds.nih.gov\/sites\/default\/files\/NIH_Stroke_Scale_Booklet.pdf\n                    \n                  . Accessed 23 Aug 2018"},{"key":"2651_CR18","unstructured":"WHO Collaborating Centre for Drugs Statistics Methodology Norwegian Institute of Public Health. \n                    https:\/\/www.whocc.no\/\n                    \n                   Accessed 9 May 2018"},{"key":"2651_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010989","volume":"6","author":"SS Mortazaxi","year":"2016","unstructured":"Mortazaxi SS, Shati M, Keshtkar A, Malakouti SK, Bazargan M, Assari S (2016) Defining polypharmacy in the elderly: a systematic review protocol. BMJ Open 6:e010989. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2015-010989","journal-title":"BMJ Open"},{"key":"2651_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s002280050329","volume":"53","author":"L Bjerrum","year":"1997","unstructured":"Bjerrum L, Rosholm J, Hallas J, Kragstrup J (1997) Methods for estimating the occurrence of polypharmacy by means of prescription database. Eur J Clin Pharmacol 53:7\u201311. \n                    https:\/\/doi.org\/10.1007\/s002280050","journal-title":"Eur J Clin Pharmacol"},{"key":"2651_CR21","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1345\/aph.1M354","volume":"43","author":"J Moen","year":"2009","unstructured":"Moen J, Antonov K, Larsson CA, Lindblad U, Nilsson JL, Rastam L et al (2009) Factors associated with multiple medication use in different age groups. Ann Pharmacother 43:1978\u20131985. \n                    https:\/\/doi.org\/10.1345\/aph.1M354","journal-title":"Ann Pharmacother"},{"key":"2651_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7957825","volume":"7957825","author":"E Kose","year":"2016","unstructured":"Kose E, Maruyama R, Okazoe S, Hayashi H (2016) Impact of polypharmacy on the rehabilitation outcome of Japanese stroke patients in the convalescent rehabilitation ward. J Aging Res 7957825:1\u20138. \n                    https:\/\/doi.org\/10.1155\/2016\/7957825","journal-title":"J Aging Res"},{"key":"2651_CR23","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios-AEMPS (2017) CIMA: Centro de informaci\u00f3n online de medicamentos de la AEMPS. \n                    https:\/\/cimaaempses\/cima\/publico\/homehtml\n                    \n                  . Accessed 18 Jul 2018"},{"key":"2651_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.wneu.2017.09.013","volume":"108","author":"R Rajagopal","year":"2017","unstructured":"Rajagopal R, Swaminathan G, Nair S, Joseph M (2017) Hyponatremia in traumatic brain injury: a practical management protocol. World Neurosurg 108:529\u2013533. \n                    https:\/\/doi.org\/10.1016\/j.wneu.2017.09.013","journal-title":"World Neurosurg"},{"key":"2651_CR25","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1080\/02699052.2018.1476733","volume":"32","author":"H Ghalaenovi","year":"2018","unstructured":"Ghalaenovi H, Fattahi A, Koohpayehzadeh J, Khodadost M, Fatahi N, Taheri M, Azimi A, Rohani S, Rahatlou H (2018) The effects of amantadine on traumatic brain injury outcome: a double blind, randomized, controlled, clinical trial. Brain Inj 32:1050\u20131055. \n                    https:\/\/doi.org\/10.1080\/02699052.2018.1476733","journal-title":"Brain Inj"},{"key":"2651_CR26","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1097\/TA.0b013e3181b16d2d","volume":"68","author":"M Carlile","year":"2010","unstructured":"Carlile M, Nicewander D, Yablon SA, Brown A, Brunner R, Burke D, Chae H, Englander J, Flanagan S, Hammond F, Khademi A, Lombard LA, Meythaler JM, Mysiw WJ, Zafonte R, Diaz-Arrastia R (2010) Prophylaxis for venous thromboembolism during rehabilitation for traumatic brain injury: a multicenter observational study. J Trauma 68:916\u2013923. \n                    https:\/\/doi.org\/10.1097\/TA.0b013e3181b16d2d","journal-title":"J Trauma"},{"key":"2651_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1620\/tjem.243.11","volume":"243","author":"S Godo","year":"2017","unstructured":"Godo S, Irino S, Nakagawa A, Kawazoe Y, Fujita M, Kudo D, Nomura R, Shimokawa H, Kushimoto S (2017) Diagnosis and management of patients with paroxysmal sympathetic hyperactivity following acute brain injuries using a consensus-based diagnostic tool: a single institutional case series. Tohoku J Exp Med 243:11\u201318. \n                    https:\/\/doi.org\/10.1620\/tjem.243.11","journal-title":"Tohoku J Exp Med"},{"key":"2651_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/JNN.0000000000000207","volume":"48","author":"S Samuel","year":"2016","unstructured":"Samuel S, Allison TA, Lee K, Choi HA (2016) Pharmacologic management of paroxysmal sympathetic hyperactivity after brain injury. J Neurosci Nurs 48:82\u201389. \n                    https:\/\/doi.org\/10.1097\/JNN.0000000000000207","journal-title":"J Neurosci Nurs"},{"key":"2651_CR29","doi-asserted-by":"publisher","first-page":"23718","DOI":"10.18632\/oncotarget.23680","volume":"9","author":"L Deng","year":"2018","unstructured":"Deng L, Qiu S, Yang Y, Wang L, Li Y, Lin J, Wei Q, Yang L, Wang D, Liu M (2018) Efficacy and tolerability of pharmacotherapy for post-stroke depression: a network meta-analysis. Oncotarget 9:23718\u201323728. \n                    https:\/\/doi.org\/10.18632\/oncotarget.23891","journal-title":"Oncotarget"},{"key":"2651_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.5535\/arm.2012.36.3.371","volume":"36","author":"YH Lim","year":"2012","unstructured":"Lim YH, Kim DH, Lee MY, Joo MC (2012) Bowel dysfunction and colon transit time in brain-injured patients. Ann Rehabil Med 36:371\u2013378. \n                    https:\/\/doi.org\/10.5535\/arm.2012.36.3.371","journal-title":"Ann Rehabil Med"},{"key":"2651_CR31","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.3748\/wjg.v13.i29.3967","volume":"13","author":"F Bracci","year":"2007","unstructured":"Bracci F, Badiali D, Pezzotti P, Scivoletto G, Fuoco U, Di Lucente L et al (2007) Chronic constipation in hemiplegic patients. World J Gastroenterol 13:3967\u20133972. \n                    https:\/\/doi.org\/10.3748\/wjg.v13.i29.3967","journal-title":"World J Gastroenterol"},{"key":"2651_CR32","unstructured":"Aubut JA, Bayley M, Lee T, Janzen S, Teasell R (2018) Neuropharmacological interventions post abi-V10-2014. In: ERABI Research Groups. Evidence-based review of moderate to severe acquired brain injury (ERABI), ABIEBR, London, Module 12. \n                    http:\/\/www.abiebr.com\/module\/12-neuropharmacology\n                    \n                  . Accessed 7 Feb 2018"},{"key":"2651_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/02699052.2017.1419377","volume":"32","author":"S Mehta","year":"2019","unstructured":"Mehta S, Mclntyre A, Janzen S, Iruthayarajah J, Bateman A, Teasell R (2019) Pharmacological management of agitation among individuals with moderate to severe acquired brain injury: a systematic review. Brain Inj 32:287\u2013296. \n                    https:\/\/doi.org\/10.1080\/02699052.2017.1419377","journal-title":"Brain Inj"},{"key":"2651_CR34","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1001\/jama.2017.21547","volume":"319","author":"A Moore","year":"2018","unstructured":"Moore A, Derry S, Wiffen P (2018) Gabapentin for chronic neuropathic pain. JAMA 319:818\u2013819. \n                    https:\/\/doi.org\/10.1002\/crossmark_policy","journal-title":"JAMA"},{"key":"2651_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1124\/pr.117.014381","volume":"70","author":"T Atkin","year":"2018","unstructured":"Atkin T, Comai S, Gobbi G (2018) Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications and discovery. Pharmacol Rev 70:197\u2013245. \n                    https:\/\/doi.org\/10.1124\/pr.117.014381","journal-title":"Pharmacol Rev"},{"key":"2651_CR36","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.rehab.2015.10.004","volume":"58","author":"M Lagalle","year":"2015","unstructured":"Lagalle M, Ruet A, Villart M, Azouvi P, Michelon H (2015) Use of psychotropic drugs in physically disabled patients: one-shot prevalence and medical practice assessment in a physical and rehabilitation medicine ward. Ann Phys Rehabil Med 58:357\u2013358. \n                    https:\/\/doi.org\/10.1016\/j.rehab.2015.10.004","journal-title":"Ann Phys Rehabil Med"},{"key":"2651_CR37","doi-asserted-by":"publisher","unstructured":"Everitt H, Baldwin DS, Stuart B, Lipinska G, Mayers A, Malizia AL et al (2018) Antidepressants for insomnia in adults Cochrane Database Syst Rev CD010753. \n                    https:\/\/doi.org\/10.1002\/14651858.CD010753.PUB2","DOI":"10.1002\/14651858.CD010753.PUB2"},{"key":"2651_CR38","doi-asserted-by":"publisher","unstructured":"Hackett ML, Yang M, Anderson CS, HorrockS JA, House A. (2012) Pharmaceutical interventions for emotionalism after stroke Cochrane Database Syst Rev CD003690. \n                    https:\/\/doi.org\/10.1002\/14651858.CD003690.PUB3","DOI":"10.1002\/14651858.CD003690.PUB3"},{"key":"2651_CR39","doi-asserted-by":"publisher","unstructured":"Giacino JT, Katz DI, Schiff ND, Whyte J, Ashman S, Barbano R et al (2018) Practice guideline update recommendations summary: disorders of consciousness: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research. Arch Phys Med Rehabil. \n                    https:\/\/doi.org\/10.1016\/j.apmr.2018.07.001","DOI":"10.1016\/j.apmr.2018.07.001"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02651-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02651-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02651-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T19:10:50Z","timestamp":1583262650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02651-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,5]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2651"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02651-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2019,3,5]]},"assertion":[{"value":"5 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}